Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, Magnesium Sulfate, and Lidocaine for Cough Suppression During Anesthetic Emergence
NCT06979141Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine, magnesium sulfate, Lidocaine Hydrochloride Injection, without epinephrine in cough, sponsored by Al-Azhar University. Started Jun 2025; status: recruiting.
02
Drugs
dexmedetomidinemagnesium sulfateLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
cough
Beyond the preview
Go deeper on NCT06979141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979141.